Arrowhead Pharmaceuticals, Inc.
USD83.28
+2.78 (+3.45%)
CEO
Christopher R. Anzalone
IPO Date
1993-12-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$82.00
Prev. Close
$80.50
Day Low
$78.86
Day High
$84.05
52W Low
$14.30
52W High
$84.55
Market Cap
$11.73B
Volume
0.80M
| 0 |
| $0.00 |
| 14 May 2026 | Lu Hongbo | director | S-Sale | Disposed | 2,970 | $76.88 |
| 24 Apr 2026 | Apel Daniel Joseph | Chief Financial Officer | S-Sale | Disposed | 3,208 | $70.11 |
| 24 Apr 2026 | Apel Daniel Joseph | Chief Financial Officer | S-Sale | Disposed | 1,157 | $70.45 |
| 24 Apr 2026 | Apel Daniel Joseph | Chief Financial Officer | S-Sale | Disposed | 8,730 | $71.92 |
| 24 Apr 2026 | Hamilton James C | Chief Medical Officer | S-Sale | Disposed | 10,000 | $75.00 |
| 9 Mar 2026 | Hamilton James C | Chief Medical Officer | S-Sale | Disposed | 10,000 | $64.19 |
| 8 Jan 2026 | Hamilton James C | Chief Medical Officer | A-Award | Acquired | 75,000 | $0.00 |
| 8 Jan 2026 | Apel Daniel Joseph | Chief Financial Officer | A-Award | Acquired | 75,000 | $0.00 |